Fibrocell Science, Inc. (FCSC) Return on Investment ROI from the third quarter of 2019 to third quarter of 2018 and for the year 2019, average high and low, overall ranking from Sep 30 2019 to Sep 30 2018 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Fibrocell Science, Inc.  (FCSC)


Fibrocell Science,'s ROI from its third quarter of 2019 to the third quarter of 2018 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Fibrocell Science,'s ROI in the third quarter of 2019?
Fibrocell Science, Inc. recorded a cumulative net loss of $-1 million during 12 months ending in the third quarter of 2019, resulting in a negative return on investment (ROI) of -6.59%.

Within the Healthcare sector 261 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2019 from 549 to 3303.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter		 (Mar 31 2019)
I. Quarter		 (Dec 31 2018)
IV. Quarter		 (Sep 30 2018)
III. Quarter
Y / Y Investment Change TTM 37.21 % 36.12 % 13.8 % -4.33 % -4.55 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 24 28 15 14 16
Return On Investment (TTM) -6.59 % 16.93 % -78.01 % -75.71 % -42.8 %
FCSC's Overall Ranking # 3303 # 549 # 0 # 0 # 0
Seq. Investment Change TTM 11.44 % 21.17 % 4.11 % -2.4 % 10.55 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -1 3 -12 -11 -6

FCSC Company Profile >> Back to FCSC Roi Comparisons >> See Annual FCSC Return On Investment



Return On Investment FCSC's Ranking
Within: No.
Industry # 87
Sector # 262
Overall # 3303

Return On Investment Statistics
High Average Low
16.93 %
-89.37 %
-177.59 %
(Jun 30 2019)   (Sep 30 2016)







Financial Statements
Fibrocell Science,'s III. Quarter Investments $ 24 Millions FCSC's Balance sheet
Fibrocell Science,'s III. Quarter Income $ -7 Millions Quarterly FCSC's Income Statement
FCSC's Income by Division See FCSC's Income by Division


FCSC Annual Return On Investment (Dec 31 2018)
2018		 (Dec 31 2017)
2017		 (Dec 31 2016)
2016		 (Dec 31 2015)
2015		 (Dec 31 2014)
2014
Total Investments in Millions 14 15 17 21 42
Y / Y Investment Growth -9.34 % -9.7 % -22.26 % -49.34 % -16.41 %
Net Income in Millions -11 -20 -15 -34 -26
Y / Y Net Income Growth - - - - -
Annual Return On Investment -79.42 % -135.72 % -92.15 % -161.4 % -60.87 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
FCSC's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for FCSC's Competitors
Subscribers only: Roi for Fibrocell Science,'s Suppliers
Subscribers only: Return On Investment for FCSC's Customers

Other Ratios
FCSC's Roa FCSC's Inventory Turnover Ratio FCSC's Growth Rates FCSC's Dividend Statistics
FCSC's Profitability Ratios FCSC's Asset Turnover Ratio FCSC's Dividend Growth
FCSC's Roe FCSC's Valuation Ratios FCSC's Financial Strength Ratios FCSC's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2019, within Healthcare Sector ROI

Date modified: 2026-09-08T15:09:43+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.